Retrosynthesis & Synthesis Planning Software Directory

Computational tools used by medicinal chemists to plan synthetic routes, assess synthesisability, and optimise reaction conditions.

Browse software
OVERVIEW

About Retrosynthesis & Synthesis Planning

Retrosynthesis & Synthesis Planning software addresses a specific bottleneck in early drug discovery: deciding whether a proposed molecule can actually be made, by what route, and at what cost in time and reagents. Medicinal chemists and computational chemists use these tools to score synthesisability before committing bench resources, to generate ranked route options for novel scaffolds, and to identify commercially available starting materials. The category sits under constant tension between coverage of published reaction space, the proprietary nature of in-house synthetic know-how, and the integration demands of electronic lab notebooks, inventory systems, and generative design pipelines that feed candidates downstream.

Two patterns stand out in this category. Every tool in the directory incorporates machine learning, reflecting how thoroughly transformer and graph-based models have displaced rule-only expert systems for disconnection prediction. Deployment is also heavily skewed toward on-premise installation, with roughly 90% offered that way and only a small share available as managed cloud. That distribution tracks the IP sensitivity of target structures and internal reaction history — pharma and biotech buyers are generally unwilling to route confidential chemistry through external infrastructure, and academic groups often want local control over training data and model behaviour.

IN OUR DATABASE

Browse Retrosynthesis Software

  • Allchemy logo

    Allchemy

    Retrosynthesis planning and molecular property prediction using expert-curated AI rules and physical organic heuristics for drug discovery.

  • Bayesian Optimization logo

    Bayesian Optimization

    Machine learning-guided reaction optimization that learns from experimental data to identify optimal conditions in fewer rounds with less material waste.

  • ChemAIRS logo

    ChemAIRS

    AI-powered retrosynthesis and synthetic pathway discovery with impurity prediction, synthesizability assessment, and process chemistry optimization.

  • Condition Optimization logo

    Condition Optimization

    AI-driven reaction condition optimization that systematically ranks feasible conditions, flags safety risks, and suggests solutions for efficient synthesis design.

  • Forward Synthesis logo

    Forward Synthesis

    Generate large-scale molecular libraries with synthesizable candidates by optimizing core structures and synthetic routes.

  • Impurity Prediction logo

    Impurity Prediction

    AI-powered prediction of impurity structures and formation pathways in chemical reactions with >90% accuracy.

  • Process Chemistry logo

    Process Chemistry

    AI-driven synthetic route optimization, reaction condition suggestions, and scale-up strategies for efficient pharmaceutical and chemical synthesis.

  • Retrosynthesis logo

    Retrosynthesis

    AI-driven retrosynthesis design generating feasible synthetic routes with machine learning and chemical intuition for novel and existing molecules.

  • SA Score logo

    SA Score

    AI-driven synthesizability assessment evaluating reaction complexity, building block availability, and cost to prioritize accessible compounds.

  • Spaya logo

    Spaya

    AI-driven retrosynthesis planning that transforms target compounds into commercially available starting materials in seconds.

FREQUENTLY ASKED QUESTIONS

Common Questions About Retrosynthesis & Synthesis Planning

SELECTED COMPANIES

Companies with the largest Retrosynthesis software portfolios

  • Chemical.AI logo

    Chemical.AI

    AI-driven retrosynthesis and synthesis planning for pharmaceutical, biotech, and CRO researchers, including synthesizability assessment and impurity prediction.

    Visit company page

  • Iktos logo

    Iktos

    Generative AI and robotics for accelerated small-molecule drug discovery, from design through preclinical candidate in under 24 months.

    Visit company page

  • SciY logo

    SciY

    Instrument integration, data standardization, and AI-readiness for research, development, and manufacturing across biopharmaceuticals, materials science, and clinical labs.

    Visit company page